| Literature DB >> 31389736 |
Matthew R Markovetz1, Durai B Subramani1, William J Kissner1, Cameron B Morrison1, Ian C Garbarine1, Andrew Ghio2, Kathryn A Ramsey1, Harendra Arora3,4, Priya Kumar3,4, David B Nix5, Tadahiro Kumagai5, Thomas M Krunkosky6, Duncan C Krause6, Giorgia Radicioni1, Neil E Alexis7, Mehmet Kesimer1,8, Michael Tiemeyer5, Richard C Boucher1, Camille Ehre1, David B Hill1,9.
Abstract
Muco-obstructive lung diseases (MOLDs), like cystic fibrosis and chronic obstructive pulmonary disease, affect a spectrum of subjects globally. In MOLDs, the airway mucus becomes hyperconcentrated, increasing osmotic and viscoelastic moduli and impairing mucus clearance. MOLD research requires relevant sources of healthy airway mucus for experimental manipulation and analysis. Mucus collected from endotracheal tubes (ETT) may represent such a source with benefits, e.g., in vivo production, over canonical sample types such as sputum or human bronchial epithelial (HBE) mucus. Ionic and biochemical compositions of ETT mucus from healthy human subjects were characterized and a stock of pooled ETT samples generated. Pooled ETT mucus exhibited concentration-dependent rheologic properties that agreed across spatial scales with reported individual ETT samples and HBE mucus. We suggest that the practical benefits compared with other sample types make ETT mucus potentially useful for MOLD research.Entities:
Keywords: cystic fibrosis; muco-obstructive lung disease; mucus; mucus biochemistry; mucus biophysics
Mesh:
Substances:
Year: 2019 PMID: 31389736 PMCID: PMC6842913 DOI: 10.1152/ajplung.00238.2019
Source DB: PubMed Journal: Am J Physiol Lung Cell Mol Physiol ISSN: 1040-0605 Impact factor: 5.464